title: Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosis.
authors.forename: David M
authors.initials: DM
authors.lastname: Burger
authors.forename: Cecile
authors.initials: C
authors.lastname: Magis-Escurra
authors.forename: Guido El
authors.initials: GE
authors.lastname: van den Berk
authors.forename: Luc B S
authors.initials: LB
authors.lastname: Gelinck
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000378:metabolism*; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage; D015498:HIV-2 / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011760:Pyrrolidinones / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000068898:Raltegravir Potassium; D012293:Rifampin / Q000008:administration & dosage; D014376:Tuberculosis / Q000188:drug therapy* / Q000276:immunology
chemical_list: D019380:Anti-HIV Agents; D000904:Antibiotics, Antitubercular; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D012293:Rifampin